Neale Cohen

Baker Heart and Diabetes Institute

Australia

Research Interests

Explore related searches

Professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Collaborators (11)

Mary Abraham

University in Western Australia

AUSTRALIA

View details

Craig Nelson

Clinical Services Director Division of Western Health @ Home/Head of Unit Nephrology

Western Health

AUSTRALIA

View details

Benjamin Lam

University of South Australia

AUSTRALIA

View details

Timothy Jones

University of Western Australia

AUSTRALIA

View details

Jonathan Williman

University of Otago

NEW ZEALAND

View details

Morton Burt

Flinders University

AUSTRALIA

View details

Sybil A. McAuley

AUSTRALIA

View details

Jennifer Halliday

Deakin University

AUSTRALIA

View details

Robyn Larsen

Lecturer

University of Melbourne

AUSTRALIA

View details

Steven Trawley

Senior Lecturer

Cairnmillar Institute

AUSTRALIA

View details

Gavin Lambert

Swinburne University of Technology

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Neale Cohen

Research Interests

Explore related searches

Contact this professor

Articles (10)

Results of an Australian trial of an automated insulin delivery (AID) system and other studies support likely benefit of AID use for many Australian adults with type 1 diabetes

Effect of Interrupting Prolonged Sitting with Frequent Activity Breaks on Postprandial Glycemia and Insulin Sensitivity in Adults with Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion Therapy: A Randomized Crossover Pilot Trial

Interrupting prolonged sitting reduces postprandial <scp>GIP</scp> but not <scp>GLP</scp>‐1 responses in type 2 diabetes

Real-world experience of adjunct weekly semaglutide in Type 1 diabetes. Is it worth it?

Study protocol for a randomised open-label clinical trial examining the safety and efficacy of the Android Artificial Pancreas System (AAPS) with advanced bolus-free features in adults with type 1 diabetes: the ‘CLOSE IT’ (Closed Loop Open SourcE In Type 1 diabetes) trial

Six months of hybrid closed-loop therapy improves diabetes-specific positive well-being, and reduces diabetes distress and fear of hypoglycemia

Asia-Pacific Perspectives on the Role of Continuous Glucose Monitoring in Optimizing Diabetes Management

Initiating or switching to insulin degludec/insulin aspart in a real-world population of adults with type 2 diabetes in Australia: results from a prospective, non-interventional study

The diabetes management experiences questionnaire

Early Discharge to Clinic-Based Therapy of Patients Presenting With Decompensated Heart Failure (EDICT-HF): Study Protocol for a Multi-Centre Randomised Controlled Trial.

Collaborators (11)

Mary Abraham

Craig Nelson

Benjamin Lam

Timothy Jones

Jonathan Williman

Morton Burt

Sybil A. McAuley

Jennifer Halliday

Robyn Larsen

Steven Trawley

Gavin Lambert

Make your next move.